Abstract
Ten-Day Decitabine with Venetoclax Versus Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia: A Propensity Score Matched Analysis
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have